A review of COVID-19 convalescent plasma use in COVID-19 with focus on proof of efficacy

Convalescent plasma (CP) therapy is rapidly becoming an established consideration in the treatment of COVID-19 patients though there is a need to critically review this area for proof of efficacy. Neutralizing antibodies (NAb) present in CP generated in response to SARS-CoV-2 infection directed agai...

Descripción completa

Detalles Bibliográficos
Autores principales: Devarasetti, Phani Kumar, Rajasekhar, Liza, Baisya, Ritasman, Sreejitha, K. S., Vardhan, Yerram Keerthi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829318/
https://www.ncbi.nlm.nih.gov/pubmed/33492637
http://dx.doi.org/10.1007/s12026-020-09169-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829318/
https://www.ncbi.nlm.nih.gov/pubmed/33492637
http://dx.doi.org/10.1007/s12026-020-09169-x

Ejemplares similares